EDIL3 and cancer: EDIL3 encodes a protein involved in angiogenesis and vessel wall remodelling, and its overexpression was reported to accelerate tumour growth by enhancing the vascular formation in hepatocellular carcinoma30, implying that EDIL3 may be a potential target for anti-angiogenic cancer therapy31.